Treatment-Nonalcoholic fatty liver disease (NAFLD)

wt loss (≥10%), exercise, DM control, liraglutide (Lancet 2016;387:679), statins (Metabolism 2017;71:17), vit E in Pts w/o DM (Hepatol 2018;67:328), bariatric surgery (World J Hepatol 2019;11:138). New therapies (eg, PPAR agonist lanifibranor, NEJM 2021;385:1547) emerging. HCC a complication of NAFLD, usually in setting of NASH cirrhosis.